AAAAAA

   
Results: 1-6 |
Results: 6

Authors: Kottakis, J Wood, R Le Gros, V Della Cioppa, G
Citation: J. Kottakis et al., Clinical efficacy with formoterol in the absence of a response to salmeterol: A review, INT J CL PR, 55(7), 2001, pp. 476-479

Authors: Eliraz, A Ramirez-Rivera, A Ferranti, P Holzer, R Garcia, JMI Turcotte, C Rapatz, G Pfister, P Overend, T Kottakis, J
Citation: A. Eliraz et al., Similar efficacy following four weeks treatment of asthmatics with formoterol 12 mu g BD delivered by two different dry powder inhalers: Differences in inhaler handling, INT J CL PR, 55(3), 2001, pp. 164-170

Authors: Benhamou, D Cuvelier, A Muir, JF Leclerc, V Le Gros, V Kottakis, J Bourdeix, I
Citation: D. Benhamou et al., Rapid onset of bronchodilation in COPD: a placebo-controlled study comparing formoterol (Foradil (R) Aerolizer (TM)) with salbutamol (Ventodisk (TM)), RESP MED, 95(10), 2001, pp. 817-821

Authors: D'Urzo, AD De Salvo, MC Ramirez-Rivera, A Almeida, J Sichletidis, L Rapatz, G Kottakis, J
Citation: Ad. D'Urzo et al., In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium - A 3-week, randomized, double-blind, within-patient, multicenter study, CHEST, 119(5), 2001, pp. 1347-1356

Authors: Sichletidis, L Kottakis, J Marcou, S Constantinidis, TC Antoniades, A
Citation: L. Sichletidis et al., Bronchodilatory responses to formoterol, ipratropium, and their combination in patients with stable COPD, INT J CL PR, 53(3), 1999, pp. 185-188

Authors: Bouros, D Bachlitzanakis, N Kottakis, J Pfister, P Polychronopoulos, V Papadakis, E Constantopoulos, S Froudarakis, M Sichletidis, L Siafakas, N
Citation: D. Bouros et al., Formoterol and beclomethasone versus higher dose beclomethasone as maintenance therapy in adult asthma, EUR RESP J, 14(3), 1999, pp. 627-632
Risultati: 1-6 |